Leading science, pioneering therapies

CRM Publications

Found 9 results
Filters: Keyword is Gene Expression Regulation, Neoplastic  [Clear All Filters]
2013
Hubert CG, Bradley RK, Ding Y, Toledo CM, Herman J, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P et al..  2013.  Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.Genes Dev. 27(9):1032-45.
Carén H, Pollard SM, Beck S.  2013.  The good, the bad and the ugly: epigenetic mechanisms in glioblastoma.Mol Aspects Med. 34(4):849-62.
Stricker SH, Feber A, Engström PG, Carén H, Kurian KM, Takashima Y, Watts C, Way M, Dirks P, Bertone P et al..  2013.  Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner.Genes Dev. 27(6):654-69.
2012
Balikova A, Jääger K, Viil J, Maimets T, Kadaja-Saarepuu L.  2012.  Leukocyte marker CD43 promotes cell growth in co-operation with β-catenin in non-hematopoietic cancer cells.Int J Oncol. 41(1):299-309.
2010
Herrero-González S, Gangoso E, Giaume C, Naus CC, Medina JM, Tabernero A.  2010.  Connexin43 inhibits the oncogenic activity of c-Src in C6 glioma cells.Oncogene. 29(42):5712-23.
Lagger S, Meunier D, Mikula M, Brunmeir R, Schlederer M, Artaker M, Pusch O, Egger G, Hagelkruys A, Mikulits W et al..  2010.  Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humans.EMBO J. 29(23):3992-4007.
2006
Prokhortchouk A, Sansom OJ, Selfridge J, Caballero IM, Salozhin S, Aithozhina D, Cerchietti L, Meng FGuo, Augenlicht LH, Mariadason JM et al..  2006.  Kaiso-deficient mice show resistance to intestinal cancer.Mol Cell Biol. 26(1):199-208.
2002
Brickman JM, Burdon T.  2002.  Pluripotency and tumorigenicity.Nat Genet. 32(4):557-8.
1992
Adams SM, Helps NR, Sharp MG, Brammar WJ, Walker RA, Varley JM.  1992.  Isolation and characterization of a novel gene with differential expression in benign and malignant human breast tumours.Hum Mol Genet. 1(2):91-6.